Antiretroviral News and Research RSS Feed - Antiretroviral News and Research

Researchers use new gene-editing system to hasten quest to cure HIV+ patients

Researchers use new gene-editing system to hasten quest to cure HIV+ patients

Researchers at UC San Francisco and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection. [More]
GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

GAFFI: Access to rapid diagnostics, antifungals could prevent over a million AIDS-related deaths by 2020

Fungal infection causes around half of AIDS-related deaths, of which there were 1,100,000 in 2015. A first of its kind analysis – ‘Modelling reduction in AIDS deaths’ by the University of Manchester’s Professor David W Denning and published today in Philosophical Transactions of the Royal Society B – suggests that the opportunity to save lives is being missed. [More]
Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

Novel ‘gene therapy in a box’ could effectively deliver modified blood stem cells

A table-top device that enables medical staff to genetically manipulate a patient's blood to deliver potential new therapies for cancer, HIV and other diseases would eliminate the need for multi-million-dollar "clean rooms," making gene therapy more possible for even the poorest of countries. [More]
New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology. [More]
UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

UCSF researchers find active HIV in tissue samples of patients treated with antiretrovirals

While successful treatment of HIV with antiretroviral medications leads to undetectable levels of virus in the blood, controls the disease and leads to much longer lifespans, scientists know that HIV continues to reside in tissues. [More]
Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Most women who used an experimental vaginal ring for HIV prevention report that the physical act of sex was largely unaffected by using the product, which is inserted monthly for continuous wear. [More]
Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys. [More]
New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

New amfAR report highlights role of health plans, health care purchasers in curbing domestic HIV epidemic

Today, amfAR, The Foundation for AIDS Research released a new report, “Curbing the HIV Epidemic by Supporting Effective Engagement in HIV Care: Recommendations for Health Plans and Health Care Purchasers,” which highlights the critical role of health plans and health care purchasers, including Medicaid and Medicare programs, marketplaces, and employers, in moving the nation toward ending the domestic HIV epidemic. [More]
WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

WHO: Countries need to move much faster to prevent, detect and treat TB to meet global targets

New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets. [More]
CCN article outlines unique treatment options for cardiovascular patients with HIV

CCN article outlines unique treatment options for cardiovascular patients with HIV

Cardiovascular disease has become the leading cause of death for those living with HIV, as the infection has moved from a terminal disease to a chronic illness. [More]
New project clarifies molecular processes involved in hidden HIV reservoir

New project clarifies molecular processes involved in hidden HIV reservoir

In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. [More]
UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

UNC secures $18 million NIH funding to form iTech for facilitating HIV research studies

People under the age of 30 account for the majority, or 40 percent, of new HIV infections in the United States. [More]
Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

Broadly neutralizing HIV antibodies open new avenues for development of effective vaccine

A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. [More]
Researchers develop innovative technique for detecting HIV hiding places in infected patients

Researchers develop innovative technique for detecting HIV hiding places in infected patients

Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS cure. [More]
Gut bacteria may play role in immune recovery of HIV patients

Gut bacteria may play role in immune recovery of HIV patients

An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients. [More]
HIV-infected adults with MDD more likely to experience heart attack, study shows

HIV-infected adults with MDD more likely to experience heart attack, study shows

Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according to a study published online by JAMA Cardiology. [More]
New method estimates patient adherence to antiretroviral drugs

New method estimates patient adherence to antiretroviral drugs

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a technique that estimates an HIVnegative patient's adherence to drugs prescribed to prevent HIV transmission during sex. [More]
Added benefit of combination drug for HIV-infected patients not proven

Added benefit of combination drug for HIV-infected patients not proven

The drug combination emtricitabine/tenofovir alafenamide is approved in combination with other antiviral agents for the treatment of adults and adolescents infected with human immunodeficiency virus type 1 (HIV-1). [More]
Research could provide new insights into finding cure for chronic infections

Research could provide new insights into finding cure for chronic infections

New research has taken us a step closer to finding a cure for human immunodeficiency virus (HIV), as well as other infections including the glandular fever virus, which is associated with the development of lymphoma. [More]
Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

Study shows link between inflammatory biomarkers and prevalence of CAD in HIV-infected men

A cardiac imaging study led by Hossein Bahrami, MD, PhD, assistant professor of cardiovascular medicine at the Keck School of Medicine of the University of Southern California, along with investigators from Johns Hopkins University and five other institutions, showed a correlation between higher inflammatory biomarkers and an increased prevalence of coronary artery disease (CAD) in men infected with human immunodeficiency virus (HIV). [More]
Advertisement
Advertisement